Related Products

Summary Of Idelalisib-API-Small Molecules

Chemical Name

Idelalisib

CAS No.

870281-82-6

Molecular Formula

C22H18FN7O

Innovator

Developer

Indication

Acute Lymphoblastic Leukemia; Allergic Rhinitis; Chronic Lymphocytic Leukemia

Therapeutic Area

Oncology; Immunology

Market Status

Launched

Approval Year

Patent Expiry